Lindbrook Capital, LLC - UNITY BIOTECHNOLOGY INC ownership

UNITY BIOTECHNOLOGY INC's ticker is UBX and the CUSIP is 91381U101. A total of 75 filers reported holding UNITY BIOTECHNOLOGY INC in Q4 2021. The put-call ratio across all filers is 5.59 and the average weighting 0.0%.

Quarter-by-quarter ownership
Lindbrook Capital, LLC ownership history of UNITY BIOTECHNOLOGY INC
ValueSharesWeighting
Q2 2022$0400.0%0.00%
Q1 2022$0400.0%0.00%
Q4 2021$0400.0%0.00%
Q3 2021$0400.0%0.00%
Q2 2021$0400.0%0.00%
Q1 2021$0400.0%0.00%
Q4 2020$0400.0%0.00%
Q3 2020$0400.0%0.00%
Q2 2020$0400.0%0.00%
Q1 2020$0400.0%0.00%
Q4 2019$0400.0%0.00%
Q3 2019$0400.0%0.00%
Q2 2019$0400.0%0.00%
Q1 2019$0400.0%0.00%
Q4 2018$0400.00%
Other shareholders
UNITY BIOTECHNOLOGY INC shareholders Q4 2021
NameSharesValueWeighting ↓
Mayo Clinic 1,571,981$8,237,0009.91%
Invus Financial Advisors, LLC 1,094,998$5,738,0002.40%
Founders Fund V Management, LLC 491,751$2,577,0000.66%
ALGERT GLOBAL LLC 51,890$272,0000.08%
Arbor Wealth Management, LLC 25,888$136,0000.05%
Moloney Securities Asset Management, LLC 41,950$220,0000.05%
PDT Partners, LLC 78,800$413,0000.03%
JACOBS LEVY EQUITY MANAGEMENT, INC 394,957$2,070,0000.02%
Fort Point Capital Partners LLC 10,000$52,0000.01%
Baillie Gifford 3,803,014$19,928,0000.01%
View complete list of UNITY BIOTECHNOLOGY INC shareholders